NCT04206241 is a clinical trial of Point of care early infant diagnosis (POC EID) in HIV/AIDS, sponsored by Elizabeth Glaser Pediatric AIDS Foundation.

Who is sponsoring NCT04206241?

NCT04206241 is sponsored by Elizabeth Glaser Pediatric AIDS Foundation.

What drugs are being tested in NCT04206241?

Interventions in NCT04206241: Point of care early infant diagnosis (POC EID).

What condition does NCT04206241 study?

NCT04206241 studies HIV/AIDS, Infant Morbidity, Perinatal HIV Infection, HIV Infections.

Is NCT04206241 still recruiting?

NCT04206241 is currently completed. Last updated 18 August 2021.

Last reviewed 2021-08-18 · How we verify

NCT04206241

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe

Completed Last updated 18 August 2021

What this trial tests

trial testing Point of care early infant diagnosis (POC EID) in HIV/AIDS in 278,833 participants. Completed in 31 December 2019.

Timeline

1 January 2018

Primary endpoint
1 November 2018

31 December 2019

Quick facts

Lead sponsor	Elizabeth Glaser Pediatric AIDS Foundation
Status	Completed
Study type	OBSERVATIONAL
Enrollment	278,833
Start date	1 January 2018
Primary completion	1 November 2018
Estimated completion	31 December 2019
Sites	10 locations across Zimbabwe

Drugs / interventions tested

Point of care early infant diagnosis (POC EID)

Conditions studied

HIV/AIDS — all drugs for HIV/AIDS →
Infant Morbidity — all drugs for Infant Morbidity →
Perinatal HIV Infection — all drugs for Perinatal HIV Infection →
HIV Infections — all drugs for HIV Infections →

Sponsor

Elizabeth Glaser Pediatric AIDS Foundation

Who can join

Under 48 Hours, any sex, with HIV/AIDS or Infant Morbidity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess the feasibility and, acceptability and effects of implementing HIV testing at birth testing using point-of-care (POC) HIV nucleic acid testing (NAT) in maternity settings.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effectiveness of Maternal Transmission Risk Stratification in Identification of Infants for HIV Birth Testing: Lessons From Zimbabwe.
Mafaune HW, Sacks E, Chadambuka A, Musarandega R, et al · · 2020 · cited 7× · PMID 32520912 · DOI 10.1097/qai.0000000000002373

Verify or expand the search:

Other recruiting trials for HIV/AIDS

Currently open trials in the same condition.

NCT06741618 — MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM · NA · recruiting
NCT07298785 — Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot Study · NA · recruiting
NCT07072481 — Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing · NA · recruiting
NCT07064785 — Video-Intervention to Inspire Treatment Adherence for Life for Adolescents · NA · recruiting
NCT07074899 — Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in Peru · NA · active not recruiting

Other Elizabeth Glaser Pediatric AIDS Foundation trials

Trials by the same sponsor.

NCT05684887 — Digital Tools to Expand COVID-19 Testing in Exposed Individuals in Cameroon · NA · completed
NCT05529771 — Clinical Outcomes of paTients pREsenting to HArare COVID-19 CenTer of Excellence With SARS-CoV-2 Infection · completed
NCT05458557 — Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus 2 · completed
NCT05382130 — INTEGrating Ag-RDTs for COVID-19 in MNCH,HIV and TB Services in Cameroon and Kenya · NA · completed
NCT05498727 — Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and Kenya · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04206241 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Elizabeth Glaser Pediatric AIDS Foundation
Last refreshed: 18 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04206241.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing